Tacrolimus is effective in both dual and triple regimens after liver transplantation

Transplantation Proceedings

Volumn 34, Issue 5, 2002, Pages 1529-1530

  Serrano, J ^a   Garcia Gonzalez M ^b   Gomez M ^c   Ortiz de Urbina, J ^d   Lopez Cillero P ^e   San Juan, F ^f   Parrilla, P ^g   Herrero, J I ^h  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c HOSPITAL JUAN CANALEJO   (Spain)

^d HOSPITAL DE CRUCES   (Spain)

^e HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^f HOSPITAL UNIVERSITARIO LA FE   (Spain)

^g HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^h UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISOLONE; TACROLIMUS;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LEUKOPENIA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OBSTRUCTIVE JAUNDICE; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREMOR; ARTICLE; CLASSIFICATION; COMPARATIVE STUDY; DRUG COMBINATION; IMMUNOLOGY; MORTALITY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; TIME;

COMPARATIVE STUDY; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TACROLIMUS; THROMBOCYTOPENIA; TIME FACTORS; HUMANS;

EID: 0035993630     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(02)03006-3     Document Type: Conference Paper

References (4)